Following intraperitoneal administration in rat models, BPC-157 increased serotonin synthesis in the substantia nigra reticulate and medial anterior olfactory nucleus
Food and Drug Administration (1)
some systems are remarkably simple, while others are more complex or require serial investigations over 48 hours
More serious deficiencies have the potential to impair heart and neurological function, leading to a wide range of serious symptoms, including but not limited to tinnitus, severe joint pain, memory problems, depression, anxiety, poor muscle function, ataxia and changes in reflexes
A: Human evidence for BPC-157 as a direct weight-loss agent is limited
The clinical trial involved 346 adults and found no difference in functional capacity, respiratory function, mental states, whole-body symptoms such as fatigue, or inflammatory markers between those treated with colchicine and those who received a placebo